Novartis to buy AveXis in $8.7bn gene-therapy deal – Reuters
Reuters |
Novartis to buy AveXis in $8.7bn gene–therapy deal
Reuters Novartis to buy AveXis in $8.7bn gene–therapy deal. 7:00am EDT – 01:28. Swiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports … |
